Etheros Pharmaceuticals Corp.
New Filing
CIK: 0002005132·Pharmaceuticals·DELAWARE·Filed: Dec 20, 2023
Total Offering
$300,000
Amount Sold
$300,000
Investors
2
First Sale
Nov 6, 2023
Offering Details
- Type
- Other: Simple agreement for future equity (SAFE)
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2022
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| John William Scannell | Related Person |
| Marc Feldmann | Related Person |
| Laura Dugan | Related Person |
| Francis Knuettel II | Related Person |
| Subhasish Chakraborty | Related Person |
Company
SEC Filing
0001839882-23-034241
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free